Besides the impact of FLT3-ITD AR in presence of a NPM1 mutation on ELN classification and allocation to conventional consolidation or upfront alloHSCT, the occurrence of FLT3-TKD mutation does not implicate alloHSCT in first CR of AML. The gene discussed is NPM1; the disease is acute myeloid leukemia.